Albireo Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

07.02.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, ALBO, PAYA (PR Newswire)
31.01.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBO, CNCE, AQUA, LPTX (PR Newswire)
23.01.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AQUA, CINC, ALBO, PAYA, GMGI (PR Newswire)
17.01.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNBE, CINC, ALBO (PR Newswire)
09.01.23	SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMYT, CINC, ALBO (PR Newswire)
09.01.23	Pre-market Movers: CINC, AMYT, ALBO, MLEC, DAWN… (RTTNews)
09.01.23	Ipsen To Buy Albireo; Acquisition To Provide Immediate Incremental Sales (RTTNews)
19.10.22	Albireo meldet positive Topline-Daten aus Phase-3-Studie zu Bylvay® (Odevixibat) beim Alagille-Syndrom (GlobeNewswire)
11.10.22	Albireo Pharma Posts Positive Topline Results From Phase 3 Study Of Bylvay In Alagille Syndrome (RTTNews)
11.10.22	Albireo Reports Positive Topline Data from Phase 3 Trial of Bylvay® (odevixibat) in Alagille Syndrome (GlobeNewswire)
06.09.22	Italian Medicines Agency Approves Reimbursed Access to Bylvay® (odevixibat) For Patients with All PFIC Types (GlobeNewswire)
30.08.22	Albireo Pharma To Announce ALGS Trial Data This Fall (RTTNews)
16.08.22	Pre-market Movers: FRZA, SVFD, MEGL, HALL, TGA… (RTTNews)
15.09.21	Albireo gibt Verfügbarkeit von Bylvay® (Odevixibat) in Deutschland ab sofort bekannt (GlobeNewswire)
24.06.21	Biotech Stocks Facing FDA Decision In July 2021 (RTTNews)
21.05.21	Albireo Pharma's Bylvay Gets Positive CHMP Opinion For PFIC Treatment (RTTNews)
21.05.21	Albireo erhält eine positive CHMP-Beurteilung für Odevixibat zur Behandlung der progressiven familiären intrahepatischen Cholestase (PFIC) (GlobeNewswire)
21.05.21	Albireo Receives Positive CHMP Opinion for Bylvay™ (odevixibat) for Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) (GlobeNewswire)
09.09.20	AZN Pauses COVID-19 Vaccine Trial, ALBO Hits New High, CRBP Plunges, PFE To Invest In TRIL (RTTNews)
08.09.20	Stock Alert: Albireo Pharma Soars 70% As Liver Drug's Late-Stage Trial Met Primary Goals (RTTNews)
08.09.20	Pre-market Movers In Healthcare Sector: ALBO, BIOC, KMDA, BNTX… (RTTNews)
19.08.20	ALBO Drops NASH Drug Development, FDA Says No To Filgotinib, SUPN On Watch, Vanda & ODYSSEY (RTTNews)
17.08.20	5 Biotech Stocks To Watch In The Coming Weeks (ALBO, ALNY, OTLK, MESO, CRBP) (RTTNews)
13.06.18	CAH Closer To FDA Approval, Another Alzheimer's Disease Drug Fails, VTVT Tanks (RTTNews)
16.04.18	ALNY On Watch, NLNK Exhibits Caution, Keep An Eye On GKOS (RTTNews)
30.01.18	ARDM Chokes, ABEO On Track, MASI Gets FDA Nod, ALBO Up 50% YTD (RTTNews)
23.10.17	DBVT Disappoints, GSK Gets Greenlight, AIMT Catches Eyes, FDA Snubs ATRS (RTTNews)
02.06.17	Company Spotlight: Albireo Pharma (RTTNews)
31.05.17	ALBO Spikes, GLYC Abuzz, FDA Approves 1st Generic Strattera For ADHD (RTTNews)
20.04.17	Gainers & Losers Of Apr.19: SNGX, IMGN, CBLI, SSH, AKTX... (RTTNews)
13.04.17	Gainers & Losers Of Apr.12: ADPT, NBIX, NOVN, PLX, ALBO... (RTTNews)
23.03.17	Gainers & Losers Of Mar.22: MBRX, IDRA, GEMP, XENE, VBLT... (RTTNews)
17.02.17	Gainers & Losers Of The Day: CRSP, XTLB, CRSP, ACUR, EVOK... (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.15	2.19 %	K V
Logitech Intl	72.20	1.66 %	K V
Lonza Grp	526.60	1.00 %	K V
Swiss Re	129.35	0.82 %	K V
UBS Group	28.35	0.18 %	K V
Givaudan	3’901.00	-0.81 %	K V
Swiss Life Hldg	725.40	-1.12 %	K V
Holcim	89.78	-1.12 %	K V
Novartis	91.93	-1.87 %	K V
Sonova Hldg	306.20	-1.89 %	K V

Nachrichten zu Albireo Pharma Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten